Activity of daptomycin or linezolid in combination with rifampin or gentamicin against biofilm-forming Enterococcus faecalis or E. faecium in an in vitro pharmacodynamic model using simulated endocardial vegetations and an in vivo survival assay usi
about
Ethanol and Isopropyl Alcohol Exposure Increases Biofilm Formation in Staphylococcus aureus and Staphylococcus epidermidis.Combination antibiotic therapy for the treatment of infective endocarditis due to enterococci.Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing.Model systems for the study of Enterococcal colonization and infection.Bacteriophage Lysin CF-301, a Potent Antistaphylococcal Biofilm Agent.Role of Combination Antimicrobial Therapy for Vancomycin-Resistant Enterococcus faecium Infections: Review of the Current Evidence.Evaluation of daptomycin combinations with cephalosporins or gentamicin against Streptococcus mitis group strains in an in vitro model of simulated endocardial vegetations (SEVs).Galleria mellonella as a model system to assess the efficacy of antimicrobial agents against Klebsiella pneumoniae infection.IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes.Emergence of linezolid resistance in hepatobiliary infections caused by Enterococcus faecium.In vivo daptomycin efficacy against experimental vancomycin-resistant Enterococcus faecium endocarditis.Vancomycin-resistant enterococcus infection in the hematopoietic stem cell transplant recipient: an overview of epidemiology, management, and prevention.Establishment and validation of Galleria mellonella as a novel model organism to study Mycobacterium abscessus infection, pathogenesis and treatment.
P2860
Q35752751-B43F58B4-F6E8-4844-8983-53E761CD17BCQ38577676-932AD14B-AD0B-47C7-991F-70E60D309129Q38686917-C7ECD6B6-7BB0-4C74-A28E-6AB0948A8CE7Q38768532-571A42A9-C836-47E5-A8D2-C83C15796A87Q38810296-5C28E733-6091-4DFB-9E99-1473EFF5B7FFQ39168565-B6423D1B-D0E0-47C2-959F-42CBC55D3F06Q40224839-A0699966-CDF5-4D2A-942E-C1B5CFF01270Q40654623-E8FAB607-4321-4F0C-9985-5AB0D72B43A3Q40991248-5F9E460B-4CF1-4C53-89EA-1DB49D554196Q41018213-F7879E45-8E50-4520-B2CB-0E2992E2FA89Q48539876-B4E6FB62-6492-4076-A798-69F7D3BC545DQ49446863-38C1E615-9136-461D-8C41-A960BF85AF34Q50044324-BA8E3309-D244-4B63-B7BA-9B5DE88169B6
P2860
Activity of daptomycin or linezolid in combination with rifampin or gentamicin against biofilm-forming Enterococcus faecalis or E. faecium in an in vitro pharmacodynamic model using simulated endocardial vegetations and an in vivo survival assay usi
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Activity of daptomycin or line ...... an in vivo survival assay usi
@en
Activity of daptomycin or line ...... an in vivo survival assay usi
@nl
type
label
Activity of daptomycin or line ...... an in vivo survival assay usi
@en
Activity of daptomycin or line ...... an in vivo survival assay usi
@nl
prefLabel
Activity of daptomycin or line ...... an in vivo survival assay usi
@en
Activity of daptomycin or line ...... an in vivo survival assay usi
@nl
P2093
P2860
P356
P1476
Activity of daptomycin or line ...... an in vivo survival assay usi
@en
P2093
Kerry L LaPlante
Marios Arvanitis
Megan K Luther
P2860
P304
P356
10.1128/AAC.02790-13
P407
P577
2014-05-27T00:00:00Z